PremiumThe FlyHarmony Biosciences CCO Jeffrey Dierks steps down, Adam Zaeske succeedsTakeda Takeda Announces Share Repurchase Program for February 2025 Takeda announces EMA approval for Takhzyro two mL pre-filled pen option PremiumPre-EarningsTAK Upcoming Earnings Report: What to Expect? Neurocrine announces amendment to collaboration with Takeda Avadel names Sev Melkonian as VP, patient services, distribution, reimbursement PremiumThe FlyKeros Therapeutics price target lowered to $43 from $100 at Truist Takeda Announces Subsidiary Liquidation and Merger Completion Hutchmed to receive milestone payment from Takeda 
